New Jersey S 990: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2018-01-16)

State: New Jersey · Session: 218 · Bill: S 990

Subjects: PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey S 990 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.